ArticleJournal of medical ultrasonics (2001)2026
Differentiation of focal liver lesions in contrast-enhanced ultrasound using a heuristic-guided hybrid machine-learning framework.
Article in Journal of medical ultrasonics (2001), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeSonazoid contrast-enhanced ultrasound (CEUS) offers valuable diagnostic information on hepatic lesions, but it is time-consuming. In this study, we investigated a novel composite machine-learning framework that integrates heuristic knowledge and model-specific classification to differentiate liver lesions using only the first 2 min of CEUS imaging.
methodsCEUS images from 232 patients with 232 focal liver lesions (benign: 61, hepatocellular carcinoma [HCC]: 104, non-HCC malignancies [ML]: 67) were analyzed. For each case, six frames from injection to peak enhancement and static images at 1 and 2 min post-injection were used. Two deep learning models were developed: Model 1 classified heterogeneous enhancement patterns into "benign," "HCC," "ML," or "Uniform" (homogeneous). Model 2 further classified "Uniform" cases into three diagnostic categories. Lesion brightness values were incorporated as input features. The artificial intelligence (AI) mode was also evaluated by observer study of three hepatologists using the area under the receiver operating characteristic curve (AUC).
resultsThe composite model was evaluated on 58 independent test cases, achieving classification accuracy of 81.8% for benign, 93.5% for HCC, and 68.8% for ML, with an overall accuracy of 84.5%. Binary classification (benign vs. malignant) yielded 97.9% sensitivity, 94.8% specificity, and 94.8% overall accuracy. For discrimination between benign and malignant, the mean AUC for the three observers was significantly improved with AI output, where the difference in AUC (95% confidence interval) was 0.095 (0.0197, 0.1703) (P = 0.013).
conclusionsThe proposed AI-based framework enables accurate liver lesion classification using early phase CEUS, eliminating the need for Kupffer-phase imaging in many cases.
Indexed as
Identifiers
41610000What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.